GUMERSINDO
PÉREZ MANGA
Investigador hasta 2009
University of Texas MD Anderson Cancer Center
Houston, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Texas MD Anderson Cancer Center (2)
2004
-
Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: Integrated efficacy data and novel analyses from two large, randomised, phase III trials
British Journal of Cancer, Vol. 90, Núm. 6, pp. 1190-1197
2002
-
First-line oral capecitabine therapy in metastatic colorectal cancer: A favorable safety profile compared with intravenous 5-fluorouracil/leucovorin
Annals of Oncology, Vol. 13, Núm. 4, pp. 566-575